Clinical Trial Site
East Brunswick, New Jersey 08816
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
— Completed